From 1980 an individual was largely treated with commercial concentrates, with there never being any discussion with his parents about that or the reasons for it. He attended a routine clinic appointment in Nottingham in April 1985 following which his blood was tested for HIV without his knowledge. Read more about From 1980 an individual was largely treated with commercial concentrates, with there never being any discussion with his parents about that or the reasons for it. He attended a routine clinic appointment in Nottingham in April 1985 following which his blood was tested for HIV without his knowledge.
A boy whose care was reviewed at Oxford was switched from cryoprecipitate to concentrates in 1976. Dr Rizza wrote to his referring haemophilia clinician advising to treat him with the N.H.S. concentrates and as a last resort it may be justified to put him onto one of the commercial Factor VIII concentrates. The reason for that recommendation was not specified and his parents were never told of any risk of infection associated with the use of factor concentrates. Read more about A boy whose care was reviewed at Oxford was switched from cryoprecipitate to concentrates in 1976. Dr Rizza wrote to his referring haemophilia clinician advising to treat him with the N.H.S. concentrates and as a last resort it may be justified to put him onto one of the commercial Factor VIII concentrates. The reason for that recommendation was not specified and his parents were never told of any risk of infection associated with the use of factor concentrates.
A man with mild haemophilia, given concentrate as part of training sessions in 1982 at the Royal Liverpool Hospital as a child, explained that his family was "told Factor VIII was safer, less bulky, easier to store and easier to use than Cryoprecipitate." He discovered he was Hepatitis C positive only in 1994 when attending a standard review at the Haemophilia Centre, not having been told that he was being tested. Read more about A man with mild haemophilia, given concentrate as part of training sessions in 1982 at the Royal Liverpool Hospital as a child, explained that his family was "told Factor VIII was safer, less bulky, easier to store and easier to use than Cryoprecipitate." He discovered he was Hepatitis C positive only in 1994 when attending a standard review at the Haemophilia Centre, not having been told that he was being tested.
In a letter Professor Bloom outlined all factor concentrate carried the risk of hepatitis, particularly non-A, non-B, and this was something that haemophiliacs would have to accept. Read more about In a letter Professor Bloom outlined all factor concentrate carried the risk of hepatitis, particularly non-A, non-B, and this was something that haemophiliacs would have to accept.
The parents of a one-year old previously untreated boy with Haemophilia A, was treated with concentrate in July 1983 at the paediatric ward at the University Hospital of Wales, were not told by any of the treating clinicians that there was a risk of NANBH, even though Professor Bloom informed the GP a few days later that "all these materials carry the risk of hepatitis, particularly non-A non-B, but this is something haemophiliacs have to accept". Read more about The parents of a one-year old previously untreated boy with Haemophilia A, was treated with concentrate in July 1983 at the paediatric ward at the University Hospital of Wales, were not told by any of the treating clinicians that there was a risk of NANBH, even though Professor Bloom informed the GP a few days later that "all these materials carry the risk of hepatitis, particularly non-A non-B, but this is something haemophiliacs have to accept".
A young man with mild Haemophilia B underwent a non-vital operation in 1984 to remove a birthmark, following which he received treatment with Factor 9 concentrate which infected him with Hepatitis C, when it was known that factor replacement therapy was potentially both HIV and Hepatitis C infectious. At no stage was any cautionary information given. He only learned that he had Hepatitis C in 1999. Read more about A young man with mild Haemophilia B underwent a non-vital operation in 1984 to remove a birthmark, following which he received treatment with Factor 9 concentrate which infected him with Hepatitis C, when it was known that factor replacement therapy was potentially both HIV and Hepatitis C infectious. At no stage was any cautionary information given. He only learned that he had Hepatitis C in 1999.
Mr and Mrs Fowle were told their son might not live another 12 years. They told Christopher of his diagnosis when he was 15. He died aged 21. Read more about Mr and Mrs Fowle were told their son might not live another 12 years. They told Christopher of his diagnosis when he was 15. He died aged 21.
Alan and Christine Fowle were called to the hopsital and told in person that their son had been infected with HIV when he was nine years old but were given no other information or advice. They were told it was generally a disease in the homosexual community exclusively. Read more about Alan and Christine Fowle were called to the hopsital and told in person that their son had been infected with HIV when he was nine years old but were given no other information or advice. They were told it was generally a disease in the homosexual community exclusively.
A mother whose son's treatment was changed from cryoprecipitate to Factor 8 concentrate was given no warnings about the products at Charing Cross Hospital Read more about A mother whose son's treatment was changed from cryoprecipitate to Factor 8 concentrate was given no warnings about the products at Charing Cross Hospital
Ms Calder did not consent to a HIV test which confirmed her son was HIV positive at 11 years old. They were informed by a letter in the post. Read more about Ms Calder did not consent to a HIV test which confirmed her son was HIV positive at 11 years old. They were informed by a letter in the post.